Gyrate atrophy of the choroid and retina: Clinical and biochemical heterogeneity and response to vitamin B6

Richard Weleber, Mary Wirtz, N. G. Kennaway

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Genetic heterogeneity in gyrate atrophy could reflect mutations at two separate loci, perhaps each coding for a separate subunit of the enzyme, or perhaps reflecting both structural and regulatory defects. There is no evidence to suggest the existence of more than one subunit of OAT, and the question of a regulatory defect in certain patients has not been examined. Presumably at least the patients in whom abnormal pyridoxal phosphate or ornithine kinetics were reported, all represent structural gene mutations. It seems more likely that genetic heterogeneity in gyrate atrophy reflects the occurrence of at least two mutant alleles at the locus for OAT. Our inability to demonstrate complementation in heterokaryons derived from B6 responsive and non-responsive patients lends support to this conclusion.

Original languageEnglish (US)
Pages (from-to)219-230
Number of pages12
JournalBirth Defects: Original Article Series
Volume18
Issue number6
StatePublished - 1982

Fingerprint

Gyrate Atrophy
Vitamin B 6
Genetic Heterogeneity
Mutation
Pyridoxal Phosphate
Ornithine
Alleles
Enzymes
Genes

ASJC Scopus subject areas

  • Developmental Biology
  • Genetics(clinical)

Cite this

@article{c162734527f74001b5a406a1cbc0da44,
title = "Gyrate atrophy of the choroid and retina: Clinical and biochemical heterogeneity and response to vitamin B6",
abstract = "Genetic heterogeneity in gyrate atrophy could reflect mutations at two separate loci, perhaps each coding for a separate subunit of the enzyme, or perhaps reflecting both structural and regulatory defects. There is no evidence to suggest the existence of more than one subunit of OAT, and the question of a regulatory defect in certain patients has not been examined. Presumably at least the patients in whom abnormal pyridoxal phosphate or ornithine kinetics were reported, all represent structural gene mutations. It seems more likely that genetic heterogeneity in gyrate atrophy reflects the occurrence of at least two mutant alleles at the locus for OAT. Our inability to demonstrate complementation in heterokaryons derived from B6 responsive and non-responsive patients lends support to this conclusion.",
author = "Richard Weleber and Mary Wirtz and Kennaway, {N. G.}",
year = "1982",
language = "English (US)",
volume = "18",
pages = "219--230",
journal = "Birth Defects: Original Article Series",
issn = "0547-6844",
publisher = "March of Dimes Birth Defects Foundation",
number = "6",

}

TY - JOUR

T1 - Gyrate atrophy of the choroid and retina

T2 - Clinical and biochemical heterogeneity and response to vitamin B6

AU - Weleber, Richard

AU - Wirtz, Mary

AU - Kennaway, N. G.

PY - 1982

Y1 - 1982

N2 - Genetic heterogeneity in gyrate atrophy could reflect mutations at two separate loci, perhaps each coding for a separate subunit of the enzyme, or perhaps reflecting both structural and regulatory defects. There is no evidence to suggest the existence of more than one subunit of OAT, and the question of a regulatory defect in certain patients has not been examined. Presumably at least the patients in whom abnormal pyridoxal phosphate or ornithine kinetics were reported, all represent structural gene mutations. It seems more likely that genetic heterogeneity in gyrate atrophy reflects the occurrence of at least two mutant alleles at the locus for OAT. Our inability to demonstrate complementation in heterokaryons derived from B6 responsive and non-responsive patients lends support to this conclusion.

AB - Genetic heterogeneity in gyrate atrophy could reflect mutations at two separate loci, perhaps each coding for a separate subunit of the enzyme, or perhaps reflecting both structural and regulatory defects. There is no evidence to suggest the existence of more than one subunit of OAT, and the question of a regulatory defect in certain patients has not been examined. Presumably at least the patients in whom abnormal pyridoxal phosphate or ornithine kinetics were reported, all represent structural gene mutations. It seems more likely that genetic heterogeneity in gyrate atrophy reflects the occurrence of at least two mutant alleles at the locus for OAT. Our inability to demonstrate complementation in heterokaryons derived from B6 responsive and non-responsive patients lends support to this conclusion.

UR - http://www.scopus.com/inward/record.url?scp=0020446165&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020446165&partnerID=8YFLogxK

M3 - Article

C2 - 7171757

AN - SCOPUS:0020446165

VL - 18

SP - 219

EP - 230

JO - Birth Defects: Original Article Series

JF - Birth Defects: Original Article Series

SN - 0547-6844

IS - 6

ER -